The Controversial Birth Control Method That's on the Rise
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
There's no denying the popularity of the Oura Ring — over two and a half million of these little wearables have been sold worldwide, according to the company. In fact, the Gen3 model was named the best overall smart ring by our tech experts in the Good Housekeeping Institute.
For the uninitiated, the Oura is a health and fitness tracker — just slide it on your finger, and it monitors 20 specific biometrics that affect different aspects of your health. Fans say they love that the Oura Ring and its app deliver real-time data analysis, offering an up-to-the-second snapshot of how your body is functioning. For example, the Oura app provides "readiness" and "sleep" scores, which you can check first thing in the morning to assess the quality of your rest. Throughout the day, you can also monitor stress levels, track your activity to evaluate workout performance and identify optimal moments for a mindful break.
'A bunch of my friends have gotten Oura Rings and have stopped using birth control,' one GH staffer reported. 'It's pretty concerning to me because I know they don't want babies right now.'
The trend is a big deal on TikTok and there is much discussion about it across social media. But is it a good idea? And does the Oura Ring actually work as birth control? and there are methods (including nonhormonal ones) with better success rates. The upshot is that the track record of the method women are using when they employ the Oura Ring as part of their birth control isn't great, even if it is much better than the same method practiced without the Oura Ring.
Oura partners with an outside app called Natural Cycles, which cites a 98% effectiveness rate at preventing pregnancy "with perfect use." This app, which is powered by the data Oura collects (it also works with Apple Watch and other devices), is FDA-cleared, . Natural Cycles works by "analyzing body temperature and other key fertility indicators to determine your daily fertility status." Natural Cycles' website slogan is "Birth control built around you."
While it's not known how many young women use the Oura combined with Natural Cycles as their sole form of contraception — or whether they were actually trying to conceive, rather than prevent pregnancy or are simply curious about their cycles — it is a popular feature: As of June 2024, , says Neta Gotlieb, Ph.D., a senior product manager for women's health at Oura.
That said, Gotlieb emphasizes.
How women are using it
Regardless, women are using the Oura Ring (in conjunction with the app) as their main birth control method. It works like this: People wear the ring to sleep, and during the night it measures body temperature, which varies slightly through a person's menstrual cycle. That data is then sent to the Natural Cycles app, which gives you a readout on your phone indicating your current level of fertility. If the app tells you it's a 'Green Day' according to your temperature, it indicates you aren't fertile that day. If the app says it's a 'Red Day,' you definitely need to use protection if you have sex.
What does body temperature have to do with fertility? There are slight variations in your body temperature throughout your cycle. The rise in progesterone after ovulation, for example, raises temperature, and if you take your temperature, it will show as slightly higher around this time. The idea is that if you've just ovulated, it's a fertile period (although you may also be also fertile before this time.) 'If you're experiencing a surge in the luteinizing hormone, or LH, that's when you're most likely to get pregnant," says Susan Mitchell-Derenkski, APRN, WHNP-BC, a nurse practitioner and OB/GYN specialist at Washington University School of Medicine's Contraceptive Choice Center in St. Louis.
The way Oura and Natural Cycles work together is essentially a new way to practice a fertility awareness-based method of birth control that has been around forever, and historically has not been very effective. 'Basal body temperature measurements have been used for decades to help women optimize the timing of intercourse during a fertile window,' according to an article in the National Library of Medicine at the National Institutes of Health (NIH). 'This unique methodology was also prevalent before the invention of oral contraception pills, as it aided women in an attempt to avoid fertilization during a fertile period.'
One difference between the way the Basal Body Temperature (BBT) method has been used by most women and is being used now with Oura Ring and Natural Cycles: Women have traditionally taken their temperature with an oral thermometer first thing in the morning and compared it to the previous days' measurements; this measures core (or basal) body temperature, or your temperature inside after a period of rest, rather than on the surface, as the ring on your finger does. One study found that measuring shell temperature throughout the night (as Oura Ring does) was slightly more sensitive than core temperature in detecting ovulation.
Are Oura Rings effective at predicting fertility?
The best answer we have to that is, paired with the Natural Cycles app, it is pretty likely to be accurate — but .
Let us explain: The ring itself does a great job measuring shell temperature, boasting a 99% lab accuracy rate and that using shell temperature instead of basal or core temperature provides more detail. Citing research, Oura says that shell temperature can even carry more information than core temperature due to the fact that your body serves as insulation. This means that your core temperature can only change in only a limited way. 'Your shell exhibits frequent, and more significant, changes in your skin temperature, while core changes can be more muffled,' the website states. Still, whether that extra detail helps pinpoint fertility is not clear. 'Overnight tracking is not necessarily more accurate than morning temperature tracking, but it is a convenient way to measure temperature if you are practicing the basal body temperature (BBT) method,' Gotlieb explains. 'Your basal body temperature is your body's temperature at complete rest or your lowest temperature. If you're using the BBT method to chart your fertility, you have to take your temperature first thing in the morning before getting out of bed, as moving around, talking, or even being awake for several minutes can affect your results.'
Presumably having Oura measure temperature at night and getting an average transmitted to your app means less human error, since if you forget to take it or jump out of bed to pee before taking your temperature, you still have accurate data. Plus, Natural Cycles says that their algorithm further reduces the chance of error. "The app has a unique and certified algorithm that adapts to each user's cycle, detecting the fertile window more accurately and removing a lot of the human error that comes with other FABMs," says Kerry Krauss, M.D., board-certified OB-GYN and Medical Director at Natural Cycles.
But how effective is the body temperature method?
It depends how you measure your temperature, but not as effective as other forms of birth control, and the reasons mostly boil down to the fact that nobody's perfect and the body isn't always predictable.
A big reason: The increase in body temperature happens after you've ovulated. "The most fertile days are the 2 to 3 days before this increase in temperature," The American College of Obstetrics and Gynecologists (ACOG) reports. A body temperature method "shows only when ovulation has already occurred, not when it is going to occur." Even though Natural Cycle's algorithm will adjust to your cycle when used over time, you may not be aware that you're fertile if your temperature hasn't yet gone up.
According to the ACOG, BBT results in one to five pregnancy out of one hundred in the first year,. This means you check your temperature every single morning at the same time when you wake up, compare it to previous days, and you are strict about not having sex at likely fertile times without a barrier method such as a condom. Natural Cycles cites a 98% effectiveness rate when used perfectly every time.
Many of us don't or can't practice this method perfectly. Even if you're using Oura Ring and you get your temperature reading automatically, you still have to remember to check the app to be sure it's a "green" day, which may not be the first thing on your mind in the throes of passion. It can also be really hard for some to forgo spontaneous sex even if you know it's risky. (And women in coercive sexual relationships with men may have even less control over when they have intercourse.)
These reasons mean that , according to ACOG. There are also reasons beyond your control: 'What if you get sick, or you become dehydrated?' says Mitchell-Derenski. 'Your temperature can be affected by these things.' Stress, smoking, drinking alcohol, having jet lag or even using an electric blanket can cause temperature changes that could throw off your result, according to Planned Parenthood.
The Natural Cycles app is better: It has been found to be 93% effective when practiced "typically," a.k.a. imperfectly. The reason it is more accurate, says Dr. Krauss, is that the algorithm becomes more accurate as it learns from your data over time, and that it errs on the side of caution. "For example, the algorithm will exclude a temperature if it detects a significant change," she says, perhaps from a night of drinking or a fever, so it doesn't factor in to the app's fertility conclusion. "It will also always err on the side of caution and give users a Red Day," indicating fertility when the data isn't clear. Because Oura also measures heart rate, says Dr. Krauss, the finding of an abnormally high heart rate, along with a higher temperature, may indicate that there are other reasons besides ovulation causing your higher body temperature.
That said, some studies have predicted that basal body temperature is only about 22% accurate in detecting ovulation. And while that one study found that using shell temperature might be slightly more accurate, we don't know how that affects the outcome. (By contrast, an IUD or implant result in less than 1% of women getting pregnant in a year.) An independent study from Sweden and Norway, found that the data Natural Cycles provides its users is sometimes not enough to prevent pregnancy, because, again, a woman has to use the app perfectly, and her timing of intercourse must also be perfect.
Lastly, it's women with very predictable cycles who do best with cycle tracking methods, she says. If you don't, it is much harder to predict ovulation.
That's what Olivia Lipski, the Good Housekeeping Institute's senior reviews writer and analyst, did in her use of the Oura Ring for almost three years. She used it initially for help growing her family, not to avoid pregnancy. 'I quickly realized how useful the ring could be,' says Lipski. 'I started digging into my Cycle Insights to get a better understanding of which phase of my cycle I was in that month, and then I paid much closer attention to the ring's body temperature tracking."
Lipski also used a separate period tracking app. "That information paired with insights into my body temperature allowed me to figure out exactly when I had ovulated — when I noticed the spike in temperature between my follicular and luteal phase that indicated ovulation had occurred, I knew I was likely fertile even if the Oura Ring didn't spell it out for me specifically,' she explains. By continuing to track her temperature after ovulation, Lipski had a happy non-surprise. 'Long story short, I knew I was pregnant before I even took a pregnancy test thanks to my Oura Ring," she says.
'You need to say, 'This is the method we are using.' Your partner must be involved in the process,' stresses Mitchell-Derenski. If you like your spontaneity and/or you and your partner want to have sex all the time, you're better off with a standard birth control method so there's no need to skip days.
This is where you check your vagina for clear mucus secretions every day after your period stops, and only have sex when you see no mucus. 'Checking for mucus can make using an Oura Ring more accurate,' says Mitchell-Derenski,
Using the Oura Ring along with Natural Cycles is not a failsafe, and to be fair, neither are some other methods (nine percent of women on the Pill will get pregnant in a year, for instance, according to ACOG, in part because they also don't use it perfectly).
To be clear, , including an IUD or an implant. In areas where access to an abortion is restricted, using only a body temperature method for birth control, unless you want a baby, can result in dire consequences.
The best thing you can do is have a chat with your healthcare provider before using any fertility tracking method.
67 Best Gifts for Women That'll Make Her Smile
The Best Pillows for Every Type of Sleeper
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
2 hours ago
- Newsweek
4-Year-Old Gets New 'Robot Arm'—Mom in Tears Over Her Response
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A girl who has spent the first four years of her life learning to manage with just one arm is finally getting her dream come true, as she prepares to get her new prosthetic. Life certainly hasn't been easy for Kaisley Hernandez, 4, who was unexpectedly born with one full arm. On her right side, her upper arm developed, but she doesn't have a forearm. It wasn't caused by amniotic band syndrome, but rather, doctors believe that her arm just stopped developing. Indeed, her mom, Destiny Hernandez, 30, told Newsweek that it came as quite the surprise because "no one knew until she was born." The limb difference didn't show up on any of her scans, so it was only when Kaisley was delivered that doctors announced that "she has a deformity." However, Kaisley, of Lubbock Texas, has refused to let her disability get her down and she has become incredibly resilient in the face of adversity. Kaisley Hernandez, 4, who was born with just part of her arm. Kaisley Hernandez, 4, who was born with just part of her arm. @dessshernandez / TikTok "Kaisley is a beautiful, smart, sassy girl, and we hope the world is kind to her," Destiny said. "We have come across her being bullied, and that was hard to see, but we just tell her that not everyone understands, and some people just aren't kind." She continued: "We encourage Kaisley and let her know that anything is possible. She can do everything she wants, and her family will be 100 percent behind her." Of course, having two arms would make life so much easier, and it turns out that Kaisley is finally getting her wish. In May 2025, the 4-year-old got her "nubby" molded for a brand-new activity prosthetic arm, which is sure to improve her life dramatically. Destiny captured the incredible moment when her daughter got the mold taken and shared the video on TikTok (@dessshernandez). The video has amazed and delighted social media users, leading to more than 13.3 million views and over 1.5 million likes on TikTok at the time of writing. During the appointment, the doctor asked Kaisley who her favorite cartoon character is, and there was only one answer for this Encanto fan: Mirabel. The sheer joy as she told the doctor she'd like Encanto-themed fabric to line her prosthetic left her mom fighting back tears. As the cast was formed around her upper arm, Kaisley was "overwhelmed with emotions." While she did seem nervous, her mom explained that it was just because she couldn't feel her nubby while it was in the mold, and it was such an unknown experience for her to face at such a young age. Thankfully, her mom and brothers were on hand to talk her through it and show her what an exciting opportunity this will be. "She is so excited, and she tells everyone 'I'm getting a robot arm.' For now, we are sticking with the activity arm until she gets older and then she can decide which direction she wants to go—there are so many options to choose from," Destiny said. Kaisley Hernandez, pictured enjoying her third birthday party with a cake and presents. Kaisley Hernandez, pictured enjoying her third birthday party with a cake and presents. @dessshernandez / TikTok On June 19, Kaisley had a fit test to check her new prosthetic, and it couldn't have gone better. The family will return on July 14 for the finishing touches. After sharing Kaisley's journey on social media, Destiny has been amazed by the supportive response. She never imagined the video would go viral, but she's glad so many people can learn about her daughter's experience, and they can cheer her on from across the world. "We just want Kaisley to have confidence, and we let her know that it's okay to ask for help," Destiny told Newsweek. Many social media users were brought to tears by Kaisley's reaction to the prosthetic mold, and the online reaction has generated over 7,000 comments on the viral post so far. One comment reads: "Poor baby, she has the best big brothers." Another TikTok user wrote: "You can see the gravity of it all just weighing on her. She's so little, but she understands it means things will be different." While another commenter added: "Bless her little heart. It must be so overwhelming for her, big change is scary for the best of us. Your family is amazing all being there together supporting her little self." Is there a health issue that's worrying you? Let us know via health@ We can ask experts for advice, and your story could be featured on Newsweek.
Yahoo
2 hours ago
- Yahoo
Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial
[212Pb]VMT-α-NET Phase 1/2a study is advancing into Cohort 3 with a fixed administered dose that is up to 20% higher (6 mCi) than the dose administered to patients in Cohort 2 Dosimetry sub-study analysis presented at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2025 Annual Meeting to advance utility of dosimetry in clinical development when considered with clinical data On track to submit further clinical updates to scientific congresses in 2H 2025, including longer safety follow-up on all patients who have received at least one treatment of [212Pb]VMT-α-NET and anti-tumor activities in patients dosed to date who have had the opportunity to receive at least one scan after their full treatment SEATTLE, June 21, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that alignment was reached with the U.S. Food and Drug Administration (FDA) to open the third dosing cohort (Cohort 3) of its ongoing Phase 1/2a clinical trial for [212Pb]VMT-α-NET in patients with unresectable or metastatic somatostatin receptor 2 (SSTR2)-positive neuroendocrine tumors (NETs) who have not received prior radiopharmaceutical therapies (RPT). "We are excited to start exploring a higher dose level of VMT-α-NET after successfully completing an interaction with the FDA that was agreed prior to commencement of this trial," commented Markus Puhlmann, Chief Medical Officer of Perspective. "We are encouraged by the overall clinical profile observed at the second dose level of VMT-α-NET—including evidence of anti-tumor activity and primarily low-grade adverse events—and we believe it is important to assess whether a higher dose could further improve the therapeutic profile. Meanwhile, we remain committed to engaging with the FDA to evaluate the clinical utility of dosimetry estimates and analyses in the development of our proprietary RPTs." Patients in Cohort 3 will receive up to four fixed administered doses of [212Pb]VMT-α-NET at 6 mCi every eight weeks if they weigh more than 60kg (133lb), or 100μCi/kg of body weight if they weigh less than or equal to 60kg. Observations of dose limiting toxicities (DLTs) in up to eight patients within 42 days of the first treatment cycle will be used to assess whether this cohort of patients have received maximum tolerated dose (MTD) or maximum feasible dose (MFD). Once a safety monitoring committee (SMC) has reviewed the data from these initial patients, it may recommend exploring alternative dosing and/or recruit more patients into Cohort 3. Perspective is notifying sites that Cohort 3 is now open for recruitment. Patients currently being evaluated for entry into the study will enroll into Cohort 3 if they qualify. Pending feedback from sites on operationalizing enrollment into Cohort 3, an update on pace of recruitment will be provided in due course. About [212Pb]VMT-α-NETPerspective designed [212Pb]VMT-α-NET to target and deliver 212Pb to tumor sites expressing SSTR2. The Company is conducting a multi-center, open-label, dose-escalation, dose-expansion study ( identifier NCT05636618) of [212Pb]VMT-α-NET in patients with unresectable or metastatic SSTR2-positive neuroendocrine tumors who have not received a prior RPT. Interim update with a data cut-off date of April 30, 2025 were reported in an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in May 2025. Cohort 2 was reopened in August 2024. During 2H 2025, some of the 33 additional patients enrolled after the cohort reopened and through April 30, 2025 will have had the opportunity for at least 32 weeks of follow-up after their initial doses, sufficient time to receive at least one scan after their full treatment (up to four doses every eight weeks), if they receive all four doses of treatment per protocol. About Perspective Therapeutics, Therapeutics, Inc. is a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. The Company is also developing complementary imaging diagnostics that incorporate the same targeting moieties, which provides the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity. The Company's melanoma (VMT01), neuroendocrine tumor (VMT-α-NET), and solid tumor (PSV359) programs are in Phase 1/2a imaging and therapy trials in the U.S. The Company is growing its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations. For more information, please visit the Company's website at Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements concerning, among other things, the Company's ability to pioneer advanced treatments for cancers throughout the body; the Company's belief that it is on track to submit further clinical updates to scientific congresses in 2H 2025 and the planned content of such updates; the Company's ability to explore a higher dose level of VMT-α-NET; the Company's commitment to engage with the FDA to evaluate the clinical utility of dosimetry estimates and analyses in the development of its proprietary RPTs; the Company's expectation that patients currently being evaluated for entry into its VMT-α-NET study will enroll into Cohort 3 if they qualify; the ability of the Company's proprietary technology utilizing the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties; the Company's prediction that the use of complementary imaging diagnostics that incorporate the same targeting moieties provides the opportunity to personalize treatment and optimize patient outcomes; the Company's belief that its "theranostic" approach enables the ability to see a specific tumor and then treat it to potentially improve efficacy and minimize toxicity; the Company's ability to grow its regional network of drug product finishing facilities, enabled by its proprietary 212Pb generator, to deliver patient-ready products for clinical trials and commercial operations; and other statements that are not historical fact. These forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from the results described in or implied by the forward-looking statements. Certain factors that may cause the Company's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are described under the heading "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC"), in the Company's other filings with the SEC, and in the Company's future reports to be filed with the SEC and available at Forward-looking statements contained in this news release are made as of this date. Unless required to do so by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Media and Investor Relations Contacts: Perspective Therapeutics IR:Annie J. Cheng, CFAir@ Russo Partners, LLCNic JohnsonPerspectiveIR@

Yahoo
5 hours ago
- Yahoo
‘I just want finality': GOP greets newest TikTok extension with resignation
President Donald Trump's latest move to keep TikTok alive is yet again frustrating congressional Republicans, many of whom object to China's continued involvement in the popular app but just want to be done with the whole drama. 'Not my favorite thing,' Sen. Josh Hawley (R-Mo.), along-time proponent of the ban, deadpanned, when asked about the president's plan to issue another extension. He spoke a day before the White House confirmed Trump signed a 90-day suspension of enforcement of the law requiring TikTok to divest from ByteDance, its China-based parent company, throwing another lifeline to the short-form video app. By Friday, some House lawmakers registered a note of resigned irritation. The extension — Trump's third since the law went into effect on Jan. 19 — is a unilateral decision not envisioned in the bipartisan law passed by Congress and upheld last year by the Supreme Court. Rep. Darin LaHood (R-Ill.), a member of the House Intelligence and China committees, told POLITICO. 'The national security concerns and vulnerabilities are still there, and they have not gone away. I would argue they've almost become more enhanced in many ways." But Trump's extension of the TikTok law largely boxed out Republicans in both chambers who have shown little inclination — beyond stern words — to prevent him from making these postponements almost routine. Many GOP lawmakers saw themselves as granting the president space to cut a promised deal while the White House deals with urgent priorities, like trade negotiations and the Israel-Iran conflict. 'In light of everything going on, I think he did the right thing,' Sen. John Kennedy (R-La.), a China hawk who voted for the ban, told POLITICO of Trump. 'I have concerns about all kinds of things — that [the extension] is on the list — but it's not at the top of the list.' Though Trump has promised his TikTok negotiations areclosely tied to trade talks with China, Treasury Secretary Scott Bessent testified last week to a Senate panel that TikTok's sale wasnot currently a part of the negotiations with China, raising a further potential obstacle to Trump inking a deal in the near future. Sen. Lindsey Graham (R-S.C.), a close ally of the president and longtime national-security hawk said earlier in the week: 'The sooner we get that issue solved, the better,' without offering any ideas for further enforcement. 'I just want finality,' Senate Judiciary Chair Chuck Grassley (R-Iowa) told POLITICO. 'I want some certainty and just know that the Congress isn't being played when we make a decision [that the app] be sold.' Another member of the House China Committee, Rep. Zach Nunn (R-Iowa), told POLITICO, 'No more extensions. It's time to follow through.' Rep. Dan Newhouse (R-Wash.), also a member of the China panel, noted in a post on X Thursday the law only allows one extension of the compliance deadline, adding, 'I was proud to support the ban of TikTok and believe the law should be implemented as written.' With their comments, the lawmakers echoed House China Chair John Moolenaar (R-Mich.), who in early June called for the U.S. to 'let [TikTok] go dark' to bring China to the table to negotiate. He reiterated that stance on Friday. 'Delays only embolden the Chinese Communist Party,' Moolenaar said in a statement to POLITICO. 'I urge the administration to enforce the law as written and protect the American people from this growing national security threat." Still, observers say Republicans are not exercising their leverage to demand the White House enforce the law they helped write, for example by withholding funding or congressional oversight hearings. "I keep reading that Republicans are 'frustrated' and 'impatient' about their TikTok law being ignored, but they should stop complaining to reporters and take it up with Trump,' said Adam Kovacevich, founder and CEO of the pro-tech Chamber of Progress. Among the Republicans being undercut by the president is his own secretary of state. Marco Rubio — who as senator was one of the loudest critics of TikTok's ties to China, and a huge backer of the app's ban — has been conspicuously silent as Trump has repeatedly granted more time to strike a deal for its sale. 'You have to decide what's more important, our national security and the threat that it poses to our national security,' Rubio told POLITICO in March 2023, as Congress was considering a ban. 'You have to weigh that against what you might think the electoral consequences of it are. For me, it's an easy balancing act. I mean, there is no balance. I'm always going to be for our national security.' A spokesperson for Rubio at the State Department did not respond to a request for comment. Democrats — even those who support keeping TikTok online — say Trump's approach is the wrong one. 'These endless extensions are not only illegal, but they also put TikTok's fate in the hands of risk-averse corporate shareholders,' Sen. Ed Markey (D-Mass.) told POLITICO in a statement. 'This is deeply unfair to TikTok's creators and users. I'm prepared to work towards a solution, but Trump isn't coming to the table.'